Health Canada drug identification number

DIN 02250896 — TARO-PHENYTOIN 125 MG

TARO-PHENYTOIN is a suspension of Phenytoin marketed by TARO PHARMACEUTICALS INC. The full Phenytoin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02250896
Brand name
TARO-PHENYTOIN
Active ingredient
Phenytoin
Strength
125 MG
Dosage form
SUSPENSION
Route
ORAL
Manufacturer
TARO PHARMACEUTICALS INC
Health Canada status
MARKETED
Drug class
Hydantoin anticonvulsant

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Phenytoin products

DINBrandStrengthFormManufacturerStatus
00022780 DILANTIN 100 MG CAPSULE BGP PHARMA ULC MARKETED
00022772 DILANTIN 30 MG CAPSULE BGP PHARMA ULC MARKETED
00023698 DILANTIN INFATABS 50 MG TABLET (CHEWABLE) BGP PHARMA ULC MARKETED
02460912 PHENYTOIN SODIUM 100 MG CAPSULE AA PHARMA INC MARKETED
00498335 PHENYTOIN SODIUM INJECTION USP 50 MG SOLUTION JUNO PHARMA CANADA INC. DORMANT
00780626 PHENYTOIN SODIUM INJECTION USP 50 MG LIQUID SANDOZ CANADA INCORPORATED MARKETED
02431378 PHENYTOIN SODIUM INJECTION USP 50 MG SOLUTION HIKMA CANADA LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.